Gastric Emptying in Neonates and Infants After Formula Feeding
Launched by COLUMBIA UNIVERSITY · Jan 25, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how quickly the stomach empties after feeding in healthy newborns and infants. Researchers will use ultrasound imaging, which is a safe and non-invasive method, to see how long it takes for clear liquids or milk (like breast milk or formula) to leave the stomach after feeding.
To be eligible for this study, babies must be healthy and full-term, meaning they are at least 36 weeks old, and either newborns aged 0-5 days or infants aged 4-6 months and 9-12 months. However, babies who needed special medical care at birth, have had prior hospital stays, or have feeding difficulties won't be able to participate. If your child is eligible and you choose to take part in the study, they will simply have their stomach monitored after being fed, which will help researchers understand gastric emptying better in young children.
Gender
ALL
Eligibility criteria
- • Inclusion criteria for study cohort are pediatric patients from Allen Hospital and Morgan Stanley Children's Hospital of New York Presbyterian Hospital who are receiving feeding by formula
- • 1. healthy full-term (postmenstrual age ≥ 36 weeks) newborns aged 0-5 days or
- • 2. healthy infants (4-6 months old and 9-12 months old)
- • Exclusion criteria are individuals who have
- • 1. newborn history of requirement resuscitation at delivery
- • 2. newborn history of admission to the Neonatal Intensive Care Unit
- • 3. any history of hospital admission
- • 4. history of gastroesophageal reflux or other feeding difficulty
- • 5. receiving any medication known to accelerate or delay gastric emptying, including but not limited to opioid-containing medications and antacids.
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Lena S. Sun, MD
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials